Feedback / Questions
visugromab (CTL-002) - CatalYm
http://clinicaltrials.gov/ct2/show/NCT07112196
Aug 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next